In this issue:
10-year monitoring, surgery or radiotherapy outcomes
DNA-repair gene mutations in metastatic prostate cancer
SBRT for localised prostate cancer
Dose-escalated EBRT plus bicalutamide
Cabozantinib in previously treated mCRPC
Prostate radiation added to ADT
Polyunsaturated fatty acids and prostate cancer risk
Nut consumption, prostate cancer risk and mortality
Gleason score 6 and 7 without cribriform or intraductal carcinoma
Conventional vs hypofractionated high-dose IMRT
Please login below to download this issue (PDF)